Status:
COMPLETED
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
Lead Sponsor:
Institute of Dermatology, Thailand
Conditions:
Alopecia Areata
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The objective of this study is to assess the safety and efficacy of Tofacitinib in treating patients with extensive and recalcitrant Alopecia Areata (AA), along with to evaluate the economic impact of...
Detailed Description
Alopecia areata (AA) or spot baldness, is a condition in which hair falls off from areas of the body. It often happens on the scalp, causing a few bald spots and it may result in psychological stress ...
Eligibility Criteria
Inclusion
- Thai volunteers age between 18 and 60 years old.
- Volunteers must be patients who suffer from severe AA more than 50% of the entire scalp.
- Volunteers must be patients who are able to complete the monthly treatment at least in the first 6 months.
Exclusion
- Patients who suffer from other hair diseases such as: Telogen effluvium, Trichotillomania, Tinea capitis
- Patients who have other diseases that can have an impact on hair loss or temporary hair loss condition with in 6 months prior to the study such as: thyroid problems, liver disease, malnutrition, hearth disease, neurological disease, gastrointestinal disorders, sexually transmitted disease, cancer, psychiatric disease.
- Patients with AA who received treatment with either steroid, Anthralin or DPCP application within 1 month before the selection or patients who had oral or injection from steroid or other medication for hair loss treatment within 3 months before the selection.
- Woman with pregnancy
Key Trial Info
Start Date :
January 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03800979
Start Date
January 12 2019
End Date
January 30 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Dermatology
Bangkok, Thailand